Stock Analysis
Global Medical REIT Inc. (GMRE) Stock Analysis
Global Medical REIT Inc. (GMRE) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Global Medical REIT Inc. (GMRE) currently has an AIQ Score of 50/100, indicating a neutral setup. Risk is the strongest factor at 78/100. Quality is the weakest current factor at 26/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
GMRE at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | — |
| AIQ Score | 50/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Buy |
| Market Cap | $478.13M |
| P/E Ratio | -137.46 |
| Forward P/E | — |
| EPS | $4.79 |
| Revenue TTM | $39.75M |
| Dividend Yield | 0.02% |
| Beta | 1.2 |
| Volume | — |
| 52-week range | — |
| RSI 14 | — |
| 50-Day SMA | $35.15 |
| 200-Day SMA | $34.10 |
| Analyst Price Target | $40.00 |
| Next Earnings | — |
GMRE
OverviewGMRE Stock Analysis Summary
Global Medical REIT Inc. (GMRE) currently has an AIQ Score of 50/100, indicating a neutral setup. Risk resilience is the strongest factor at 78/100. Quality is the weakest current factor at 26/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, GMRE has AIQ Score of 50/100 with Risk resilience base of 78/100 and fading Quality at 26/100. Wait for component alignment before adding exposure.
Risk resilience (78/100) leads while Quality (26/100) lags. This cross-factor spread creates entry timing uncertainty.
Real Estate · — stock move · GMRE classified in REIT - Healthcare Facilities.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is GMRE Bullish or Bearish Right Now?
GMRE currently has a neutral overall setup. Risk Resilience is the strongest factor at 78/100, while Quality is weakest at 26/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Risk Resilience is supportive at 78/100.
- - Technical consensus has more buy votes than sell votes (25 vs 10).
- - No strong bearish evidence is available in the current snapshot.
Current Consensus
GMRE's Technical Analysis Consensus is currently Buy, with 25 buy, 10 neutral, and 10 sell votes. GMRE's beta is 1.2, indicating greater market sensitivity than the broad market.
What Changed in GMRE?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the GMRE Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
GMRE Decision Framework
Public evidence layers, setup checks, and risk context for Global Medical REIT Inc..
Global Medical REIT Inc. (GMRE) Stock Analysis
Global Medical REIT Inc. has an AIQ Score of 50/100 in a Neutral regime. Risk is strongest at 78/100. Beta is 1.2, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | GMRE is in a Neutral AIQ regime with score 50/100. |
| Signal Conflict | The primary conflict is that risk leads at 78/100 while quality lags at 26/100. |
| Factor Evidence | Value 60/100 · Quality 26/100 · Risk 78/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Risk is the strongest factor at 78/100.
Momentum is — and RSI (14) is 65.4.
GMRE is in a Neutral regime at 50/100.
Risk factor is 78/100 with beta 1.2 and annual volatility 29.46%.
Current conflict: risk leads at 78/100 while quality lags at 26/100.
GMRE Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
GMRE Fundamentals
GMRE valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
GMRE Technical Analysis
GMRE technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
GMRE Stock Catalysts
Track GMRE earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
GMRE Dividend Analysis
GMRE dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
GMRE Financial Data
GMRE revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
GMRE Risk Analysis
GMRE volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
GMRE Stock News
GMRE stock news, market tone, recent headlines, and catalyst context.
GMRE vs REITs — Healthcare / Self-Storage / Hotels Peers
Current peer cohort: GMRE · HR · HST · IIPR · LTC. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| GMRE Current stock | 50/100 | 60/100 | — | 78/100 | 0.65 | 29.46% | Current |
| HR Healthcare Realty Trust | 42/100 | 61/100 | 34/100 | 57/100 | 0.05 | 19.34% | GMRE vs HR |
| HST Host Hotels & Resorts | 51/100 | 68/100 | 32/100 | 75/100 | 0.9 | 25.28% | GMRE vs HST |
| IIPR Innovative Industrial Properties | 57/100 | 60/100 | 46/100 | 61/100 | 0.08 | 38.38% | GMRE vs IIPR |
| LTC LTC Properties | 64/100 | 58/100 | 79/100 | 52/100 | 0.63 | 20.41% | GMRE vs LTC |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts7 recent quarterly periods are available for review.
Checked Sep 12, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching GMRE
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for GMRE
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
GMRE Stock FAQ
What is GMRE stock price today?
Global Medical REIT Inc.'s current stock price is shown near the top of this overview when the latest quote is available. Use the quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is GMRE bullish or bearish right now?
GMRE's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is GMRE's market cap?
GMRE's market cap is $478.13M based on the latest completed market-close snapshot from Sep 12, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is GMRE's current P/E ratio?
GMRE's current P/E ratio is -137.46 based on the latest completed market-close snapshot from Sep 12, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is GMRE's RSI?
GMRE's RSI appears in the technical analysis view when market-close technical data is available. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is GMRE above its 50-day and 200-day moving averages?
GMRE's price versus the 50-day and 200-day moving averages helps describe trend confirmation. The overview and technicals page show this context when those moving-average fields are available.
When is GMRE's next earnings date?
GMRE's next earnings date is a key event to check before making a decision. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does GMRE pay a dividend?
GMRE's dividend yield is 0.02% based on the latest completed market-close snapshot from Sep 12, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.